摘要
目的观察巴曲酶治疗突发性耳聋对FDP与D二聚体比值的影响。方法选取本院2020年4月-2021年4月收治的60例突发性耳聋患者为研究对象,按照是否应用巴曲治疗将患者分为对照组(30例:未应用巴曲酶治疗)与实验组(30例:应用巴曲酶治疗),比较两组患者治疗效果。结果实验组患者治疗后凝血酶功能指标、纤溶蛋白溶解功能以及FDP与D二聚体比值均优于对照组,数据差异有统计学意义(P<0.05)。结论突发性耳聋患者巴曲酶治疗在改善患者凝血酶功能指标、纤溶蛋白溶解功能,提升治疗效果的同时可提升FDP与D二聚体比值。
Objective To observe effect of batroxobin therapy on FDP to D-dimer ratio for sudden deafness.Methods The paper chose 60 patients with sudden deafness admitted to our hospital from April 2020 to April 2021 as research objects,and divided them into control group(30 cases:treated with no batroxobin)and experimental group(30 cases:with batroxobin)based on batroxobin treatment or not.Treatment effect between two groups was compared.Results Thrombin function indicators,fibrinolytic function,and FDP to D-dimer ratio of experimental group were better than control group after treatment,with statistically significant difference(P<0.05).Conclusion Batroxobin therapy can improve thrombin function indicators,fibrinolytic function,and enhance treatment effect of patients with sudden deafness,and increase ratio of FDP to D-dimer.
作者
陆伟伟
任晓丹
宁永忠
曹丽娜
LU Weiwei;REN Xiaodan;NING Yongzhong;CAO Lina(Laboratory Department,Beijing Zhuoyangliu Hospital,Beijing 100022)
出处
《智慧健康》
2023年第10期118-121,共4页
Smart Healthcare
